Hubbry Logo
MEDAMEDAMain
Open search
MEDA
Community hub
MEDA
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
MEDA
from Wikipedia
MEDA
Clinical data
Other names3-Methoxy-4,5-ethylenedioxyamphetamine; 5-Methoxy-3,4-ethylenedioxyamphetamine; 5-Methoxy-EDA; 5-MeO-EDA
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC12H17NO3
Molar mass223.272 g·mol−1
3D model (JSmol)
  • NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 ☒N
  • Key:NRVFDGZJTPCULU-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

MEDA, also known as 3-methoxy-4,5-ethylenedioxyamphetamine or as 5-methoxy-EDA, is a chemical compound of the phenethylamine, amphetamine, and EDxx families.[1][2] It is the EDxx analogue of the MDxx psychedelic and entactogen MMDA (5-methoxy-MDA).[1][2][3] In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MEDA's dose as greater than 200 mg orally and its duration as unknown.[1][2] MEDA produced few to no effects.[1][2] The chemical synthesis of MEDA has been described.[1] MEDA was first described in the scientific literature by Shulgin in 1964.[3] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
Add your contribution
Related Hubs
User Avatar
No comments yet.